Today a powerful statement was issued by the Foundation created to carry on the legacy of Representative Tom Lantos, the US legislator and Holocaust survivor who, before he passed away, played a leading role in reauthorizing PEPFAR. The Lantos Foundation is chaired by Lantos’ widow, Annette Lantos. Read the full statement. An excerpt: “Before he died, [Tom […]
As we head into the International Aids Conference next week, here are a few stories and posts to get your wheels turning. Stay tuned for live blogging from the Conference. News came this week of an antibody that can kill 91% of strains of HIV, bringing hope for an effective vaccine against the virus. A […]
Wearing an AIDS red ribbon on this lapel, Ezekiel Emanuel, MD, a special advisor to the White House on health policy, participated in a panel discussion this morning during an IAS 2010 pre-meeting entitled “Bridging the Divide – Inter-Disciplinary Partnerships for HIV and Health Systems Strengthening.” “This is a challenge to everyone — Partially to […]
Eric Goosby, MD, head of the U.S. government Office for Global AIDS, posted a blog on July 13 that outlines his recent trip to Uganda and highlights actions underway to ensure that treatment scale-up continues in that African nation. The blog post and its outlined actions would appear to be a response to concerns raised […]
The 2010 International AIDS Conference starts on Sunday. Ken Mayer, MD, is on his way to Vienna to participate, and ScienceSpeaks interviewed him briefly about what studies he anticipates regarding prevention as treatment and other topics at the conference. Kenneth H. Mayer, MD is a Professor of Medicine & Community Health at Brown University and […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
With a report showing that 2018 yielded the highest case numbers seen so far of a paralyzing condition largely among children who had been sick with […]